Susana Santos

Prof. Susana Santos

orcid

Research Focus & Metrics

Academic Career Length

39Years (1988-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 February 2014 in Marine Drugs
Verified
Journal Article
Open access
PDF file
ARAna Rodrigues-Martins
Ana Rodrigues-Martins
HVHelena Vieira
Helena Vieira
Helena GasparHelena Gaspar
Helena Gaspar
SSSusana Santos
Susana Santos
The marine environment harbors a number of macro and micro organisms that have developed unique metabolic abilities to ensure their survival in diverse and hostile habitats, resulting in the biosynthesis of an array of secondary metabolites with specific activities. Several of these metabolites are high-value commercial products for the pharmaceutical and cosmeceutical industries. The aim of this review is to outline the paths of marine natural products discovery and development, with a special focus on the compounds that successfully reached the market and particularly looking at the approaches tackled by the pharmaceutical and cosmetic companies that succeeded in marketing those products. The main challenges faced during marine bioactives discovery and development programs were analyzed and grouped in three categories: biodiversity (accessibility to marine resources and efficient screening), supply and technical (sustainable production of the bioactives and knowledge of the mechanism of action) and market (processes, costs, partnerships and marketing). Tips to surpass these challenges are given in order to improve the market entry success rates of highly promising marine bioactives in the current pipelines, highlighting what can be learned from the successful and unsuccessful stories that can be applied to novel and/or ongoing marine natural products discovery and development programs.

1 June 2014 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
FMFilomena Martins
Filomena Martins
SSSusana Santos
Susana Santos
CVCristina Ventura
Cristina Ventura
RERuben Elvas-Leitão
Ruben Elvas-Leitão
LSLidia Santos
Lidia Santos
MVMiguel Viveiros
Miguel Viveiros

23 December 2011 in Journal of Chemical & Engineering Data
Verified
Journal Article
Closed access
Clara RàfolsClara Ràfols
Clara Ràfols
EBElisabeth Bosch
Elisabeth Bosch
RRRebeca Ruiz
Rebeca Ruiz
KBKarl J. Box
Karl J. Box
MRMarina Reis
Marina Reis
FMFilomena Martins
Filomena Martins

1 December 2019 in NeuroToxicology
Verified
Journal Article
Closed access
JSJorge Soares
Jorge Soares
Vera CostaVera Costa
Vera Costa
Helena GasparHelena Gaspar
Helena Gaspar
SSSusana Santos
Susana Santos
MBMaria de Lourdes Bastos
Maria de Lourdes Bastos
João Paulo CapelaJoão Paulo Capela
João Paulo Capela

1 September 2018 in Forensic Science International
Verified
Journal Article
Closed access
Helena GasparHelena Gaspar
Helena Gaspar
SBSoraia Bronze
Soraia Bronze
COCatarina Oliveira
Catarina Oliveira
BVBruno L. Victor
Bruno L. Victor
Miguel MachuqueiroMiguel Machuqueiro
Miguel Machuqueiro
SSSusana Santos
Susana Santos

1 December 2021 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Open access
CFCatarina Frazão de Faria
Catarina Frazão de Faria
TMTânia Moreira
Tânia Moreira
PLPedro Lopes
Pedro Lopes
HCHenrique Costa
Henrique Costa
JKJessica R. Krewall
Jessica R. Krewall
FMFilomena Martins
Filomena Martins
Isoniazid (INH) is one of the two most effective first-line antitubercular drugs and is still used at the present time as a scaffold for developing new compounds to fight TB. In a previous study, we have observed that an INH derivative, an hydrazide N'-substituted with a C10acyl chain, was able to counterbalance its smaller reactivity with a higher membrane permeability. This resulted in an improved performance against the most prevalent Mycobacterium tuberculosis (Mtb) resistant strain (S315T), compared to INH. In this work, we have designed two new series of INH derivatives (alkyl hydrazides and hydrazones) with promising in silico properties, namely membrane permeabilities and spontaneous IN* radical formation. The kinetics, cytotoxicity, and biological activity evaluations confirmed the in silico predictions regarding the very high reactivity of the alkyl hydrazides. The hydrazones, on the other hand, showed very similar behavior compared to INH, particularly in biological tests that take longer to complete, indicating that these compounds are being hydrolyzed back to INH. Despite their improved membrane permeabilities, the reactivities of these two series are too high, impairing their overall performance. Nevertheless, the systematic data gathered about these compounds have showed us the need to find a balance between lipophilicity and reactivity, which is paramount to devise better INH-based derivatives aimed at circumventing Mtb resistance.